Respiratory Strategic Vision

Inke is specialised in the development and manufacturing of active ingredients for use in Respiratory Inhalation therapies for the last two decades.

Our unwavering commitment ensures that they receive the highest quality assistance to achieve their goals. With a strategic vision deeply rooted in respiratory care, we specialize in the development and manufacturing of high-added-value active ingredients tailored specifically for inhalation therapies. For over two decades, Inke has led the charge in technology, driving the evolution of respiratory active pharmaceutical ingredients to meet the ever-evolving needs of patients and healthcare providers worldwide.

Global Reach, Local Expertise

As a trusted partner to major generic and branded companies, Inke has solidified its position as a key supplier in the global pharmaceutical landscape. Headquartered in Barcelona, Spain, our reach extends far beyond borders, with a continuous international expansion spanning over two decades. From Europe to the United States, Japan, Korea, and China, Inke delivers cutting-edge APIs to every corner of the globe, advancing respiratory care and improving patient outcomes on a global scale.

Canada, USA & Mexico

For detailed information on this market, please reach out to Eric Bouillet.

Japan

For detailed information on this market, please reach out to Mónica Capón

Africa

Turkey, South Africa, MENA (Egypt, Algeria, Morocco & Tunisia)

For detailed information on this market, please reach out to Maite Pascual.

India, Bangladesh & Pakistan

For detailed information on this market, please reach out to Maite Pascual.

INKE S.A.

Main Offices:

Avinguda Diagonal, 605 6D,
08028 Barcelona, Spain

Manufacturing Site:

Area Industrial del Llobregat,
Argent 1, 08755 Castellbisbal
Barcelona, Spain

LATAM

Argentina & Brazil

For detailed information on this market, please reach out to Maite Pascual.

Europe

For detailed information on this market, please reach out to Anna Homs.

Spain

For detailed information on this market, please reach out to Maite Pascual.

Asia & Oceania

China, Korea, Taiwan and Southest Asia (Vietnam, Philippines, Thailand & Malaysia), Australia & New Zealand

For detailed information on this market, please reach out to Harry Yuan.

Respiratory Focus

Discover Inke's Difference

Explore how Inke’s unparalleled expertise and unwavering commitment to respiratory health are shaping the future of inhalation therapies. Learn more about our innovative solutions and discover why leading pharmaceutical companies trust Inke as their preferred partner in respiratory care.

Respiratory APIs in the Main Markets Worldwide

USDMFs

Respiratory APIs
  • Aclidinium bromide
  • Arformoterol tartrate (A)
  • Arformoterol tartrate (D)
  • Formoterol fumarate dihydrate
  • Glycopyrronium bromide
  • Indacaterol maleate
  • Olodaterol hydrochloride
  • Revefenacin trihydrate
  • Salmeterol xinafoate
  • Tiotropium bromide monohydrate
  • Umeclidinium bromide
  • Vilanterol trifenatate

CEPs/EU DMFs

Respiratory APIs
  • Aclidinium bromide
  • Formoterol fumarate dihydrate
  • Glycopyrronium bromide
  • Indacaterol maleate
  • Montelukast sodium
  • Olodaterol hydrochloride
  • Revefenacin trihydrate
  • Salmeterol xinafoate
  • Tiotropium bromide monohydrate
  • Vilanterol trifenatate
  • Umeclidinium bromide

Know more about our Respiratory Solutions

Explore Our Full Range of Respiratory APIs

Dive into our extensive product portfolio and discover the

high-quality respiratory APIs designed to meet your needs.

Access to detailed information and download product PDFs

by filling the form at the end of the page.